395 related articles for article (PubMed ID: 24614140)
41. Management of AIDS-related non-Hodgkin's lymphomas.
Kersten MJ; Van Oers RH
Drugs; 2001; 61(9):1301-15. PubMed ID: 11511024
[TBL] [Abstract][Full Text] [Related]
42. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
43. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
Cochrane Database Syst Rev; 2014; (9):CD003256. PubMed ID: 25313415
[TBL] [Abstract][Full Text] [Related]
44. The pathogenesis of AIDS lymphomas: a foundation for addressing the challenges of therapy and prevention.
Karp JE; Broder S
Leuk Lymphoma; 1992 Oct; 8(3):167-88. PubMed ID: 1362682
[TBL] [Abstract][Full Text] [Related]
45. AIDS-Associated Malignancies.
Vangipuram R; Tyring SK
Cancer Treat Res; 2019; 177():1-21. PubMed ID: 30523619
[TBL] [Abstract][Full Text] [Related]
46. Therapy insight: AIDS-related malignancies--the influence of antiviral therapy on pathogenesis and management.
Yarchoan R; Tosato G; Little RF
Nat Clin Pract Oncol; 2005 Aug; 2(8):406-15; quiz 423. PubMed ID: 16130937
[TBL] [Abstract][Full Text] [Related]
47. Nursing challenges of caring for patients with HIV-related malignancies.
Moran TA
Oncology (Williston Park); 1996 Oct; 10(10):1509-16; discussion 1523-4, 1527. PubMed ID: 8905843
[TBL] [Abstract][Full Text] [Related]
48. [Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history].
Juzbasic S; Spina M; Vaccher E; Tirelli U
Recenti Prog Med; 2001 Nov; 92(11):676-89. PubMed ID: 11765662
[TBL] [Abstract][Full Text] [Related]
49. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy.
Ratner L; Lee J; Tang S; Redden D; Hamzeh F; Herndier B; Scadden D; Kaplan L; Ambinder R; Levine A; Harrington W; Grochow L; Flexner C; Tan B; Straus D;
J Clin Oncol; 2001 Apr; 19(8):2171-8. PubMed ID: 11304769
[TBL] [Abstract][Full Text] [Related]
50. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
Gabarre J; Bossi P
Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
[TBL] [Abstract][Full Text] [Related]
51. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.
Antinori A; Cingolani A; Alba L; Ammassari A; Serraino D; Ciancio BC; Palmieri F; De Luca A; Larocca LM; Ruco L; Ippolito G; Cauda R
AIDS; 2001 Aug; 15(12):1483-91. PubMed ID: 11504980
[TBL] [Abstract][Full Text] [Related]
52. HIV-associated lymphomas.
Straus DJ
Curr Oncol Rep; 2001 May; 3(3):260-5. PubMed ID: 11296137
[TBL] [Abstract][Full Text] [Related]
53. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
54. [GESIDA/PETHEMA guidelines for the diagnosis and treatment of lymphomas in HIV-infected patients].
Miralles P; Berenguer J; Ribera Santasusana JM; Calvo F; Díaz Mediavilla J; Díez-Martín JL; Gomez Codina J; López Aldeguer J; Rubio R; Santos J; Valencia E
Med Clin (Barc); 2008 Mar; 130(8):300-11. PubMed ID: 18358123
[No Abstract] [Full Text] [Related]
55. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
Montoto S; Shaw K; Okosun J; Gandhi S; Fields P; Wilson A; Shanyinde M; Cwynarski K; Marcus R; de Vos J; Young AM; Tenant-Flowers M; Orkin C; Johnson M; Chilton D; Gribben JG; Bower M
J Clin Oncol; 2012 Nov; 30(33):4111-6. PubMed ID: 23045581
[TBL] [Abstract][Full Text] [Related]
56. Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).
Hentrich M; Hoffmann C; Mosthaf F; Müller M; Siehl J; Wyen C; Hensel M; ;
Ann Hematol; 2014 Jun; 93(6):913-21. PubMed ID: 24807241
[TBL] [Abstract][Full Text] [Related]
57. Lung Malignancies in HIV Infection.
Sigel K; Pitts R; Crothers K
Semin Respir Crit Care Med; 2016 Apr; 37(2):267-76. PubMed ID: 26974303
[TBL] [Abstract][Full Text] [Related]
58. High-dose therapy and autologous stem cell transplantation for children with HIV-associated non-Hodgkin lymphoma.
Fluri S; Ammann R; Lüthy AR; Hirt A; Aebi C; Duppenthaler A; Leibundgut K
Pediatr Blood Cancer; 2007 Dec; 49(7):984-7. PubMed ID: 16685736
[TBL] [Abstract][Full Text] [Related]
59. New controversies and new directions.
Ambinder RF
Curr Opin Oncol; 2000 Sep; 12(5):435-7. PubMed ID: 10975550
[No Abstract] [Full Text] [Related]
60. [Lymphomas in children infected with HIV-1].
Gandemer V; Verkarre V; Quartier P; Brousse N; Blanche S
Arch Pediatr; 2000 Jul; 7(7):738-44. PubMed ID: 10941489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
